Interactions of Apolipoproteins with Lipid-Based Nanoparticles

Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design

(2022) Kai Liu et al.   Nanoscale

Identifying cell receptors for the nanoparticle protein corona using genome screens

(2022) Wayne Ngo et al.   Nature Chemical Biology

Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery

(2022) Natalie Boehnke et al.   SCIENCE

Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation

(2021) Sara Sheibani et al.   Nature Communications

Elongated PEO-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger receptor class B I (SR-BI)

(2021) Mitch Raith et al.   JOURNAL OF CONTROLLED RELEASE

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

(2021) Julian D. Gillmore et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Macrophages in Tumor Immunity

(2020) Yueyun Pan et al.   Frontiers in Immunology

Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles

(2019) Katrin Partikel et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

The hard protein corona of stealth liposomes is sparse

(2019) Kasper Kristensen et al.   JOURNAL OF CONTROLLED RELEASE

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

(2017) Nicolas Bertrand et al.   Nature Communications

Effects of the protein corona on liposome–liposome and liposome–cell interactions

(2016) Ennio Tasciotti et al.   International Journal of Nanomedicine

Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking dyslipidemia with obesity

(2016) Ying Du et al.   Journal of Translational Medicine

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

(2016) Marilena Hadjidemetriou et al.   Nanoscale

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Effect of the beta-3 adrenergic receptor Trp64Arg and uncoupling protein 1–3826 A > G genotypes on lipid and apolipoprotein levels in overweight/obese and non-obese Chinese subjects

(2015) Yihong Chen et al.   Lipids in Health and Disease

Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E

(2015) Ana Rute Neves et al.   NANOTECHNOLOGY

Phosphatidylcholine biosynthesis and lipoprotein metabolism

(2011) Laura K. Cole et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

A Phospholipidomic Analysis of All Defined Human Plasma Lipoproteins

(2011) Monireh Dashti et al.   Scientific Reports

A Guide to Simple and Informative Binding Assays

(2010) Thomas D. Pollard   MOLECULAR BIOLOGY OF THE CELL

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

(2010) Akin Akinc et al.   MOLECULAR THERAPY

Molecular Mechanism of Apolipoprotein E Binding to Lipoprotein Particles†

(2009) David Nguyen et al.   BIOCHEMISTRY

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

(2008) M. Lundqvist et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA